Dobesilic acid

DB13529InvestigationalSmall molecule

Dobesilic acid is a medication indicated in the treatment of hemorrhoids, venous insufficiency, and other microangiopathies. A medication used to treat hemorrhoids and other blood circulation disorders.

Chemical structure of Dobesilic acid
Mechanism
Curator reviewed
Formula / weight
C6H6O5S · 190.174 g/mol (avg)

Resolves to

Compound
UNIITO0PAT081ICAS88-46-0ChEMBLCHEMBL1232131ChEBI71157
Clinical / RWD
RxNorm235935ATCC05BX01ATCC05BX51
Structure
InChIKeyIKQCSJBQLWJEPU-UHFFFAOYSA-NSMILESOC1=CC(=C(O)C=C1)S(O)(=O)=O
Targets
P35968KDRP0DTC2S

What you can answer from here — as of September 14, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
17Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
18Marketed productsAcross 5 countries and 9 labellers
Sign in
2ATC codesIncluding every combination product, plus 12 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dobesilic acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In